Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Giulio C. Spagnoli(National Academies of Sciences, Engineering, and Medicine), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Maria Irno Consalvo(University of Rome Tor Vergata), Gabriele Toietta(National Cancer Institute), Giandomenica Iezzi(Ente Ospedaliero Cantonale), Roberto Arriga(University of Rome Tor Vergata), Alessio Ottaviani(Istituto di Farmacologia Traslazionale), Luca Maurillo(University of Rome Tor Vergata), Sara Caratelli(National Academies of Sciences, Engineering, and Medicine), Silvia Baldari(Istituti di Ricovero e Cura a Carattere Scientifico), Giulia Lanzilli(Istituto di Farmacologia Traslazionale), Valeriana Cesarini(University of Rome Tor Vergata), Maria Ilaria Del Principe(University of Rome Tor Vergata), Tommaso Sconocchia(Istituto di Farmacologia Traslazionale), Carlo Cenciarelli(Istituto di Farmacologia Traslazionale), Anna Aureli(Istituto di Farmacologia Traslazionale), Francesca De Paolis(Istituto di Farmacologia Traslazionale), Ken Chen(Center for Personalized Cancer Treatment), Jinzhuang Dou(The University of Texas MD Anderson Cancer Center), Francesco Buccisano(University of Rome Tor Vergata), Adriano Venditti(University of Rome Tor Vergata), Domenico Alessandro Silvestris(Bambino Gesù Children's Hospital)
Cited by 6
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Somatic mutations affect key pathways in lung adenocarcinoma
|Nature|2008|2.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k